Issued Patents All Time
Showing 1–12 of 12 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12325754 | Cancer and B-cell related disease therapy | Aymen Al-Shamkhani, Mark Cragg, Sean Lim | 2025-06-10 |
| 11780929 | Immunomodulatory antibodies | Aymen Al-Shamkhani, Hak Tak Claude Chan, Mark Cragg, Ruth Rosemary French, Jane Elizabeth Willoughby | 2023-10-10 |
| 11623005 | Combined use of FcγRIIb (CD32B) and CD20 specific antibodies | Mark Cragg, Ali Roghanian, Stephen Beers, Peter Johnson, Sean Lim +2 more | 2023-04-11 |
| 11447549 | Combination of a Treg depleting anti-4-1BB antibody and anti-PD1 antibody | Björn Frendéus, Linda MÅRTENSSON, Monika SEMMRICH, Ingrid Teige, Stephen Beers +2 more | 2022-09-20 |
| 11059898 | Modified antibodies containing modified IGG2 domains which elicit agonist or antagonistic properties and use thereof | Ann White | 2021-07-13 |
| 11001638 | Immunomodulatory antibodies | Aymen Al-Shamkhani, Hak Tak Claude Chan, Mark Cragg, Ruth Rosemary French, Jane Elizabeth Willoughby | 2021-05-11 |
| 10525129 | Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies | Mark Cragg, Ali Roghanian, Stephen Beers, Peter Johnson, Sean Lim +2 more | 2020-01-07 |
| 9926374 | Human immune therapies using a CD27 agonist in combination with another immune agonist to treat cancer | Alison Louise Tutt, Aymen Al-Shamkhani | 2018-03-27 |
| 9248183 | Human immune therapies using a CD27 agonist alone or in combination with other immune modulators | Alison Louise Tutt, Aymen Al-Shamkhani | 2016-02-02 |
| 8529902 | Human monoclonal antibodies against CD20 | Jessica Teeling, Sigrid Ruuls, Jan Van De Winkel, Paul Parren, Jørgen Petersen +2 more | 2013-09-10 |
| 8481029 | Human immune therapies using a CD27 agonist alone or in combination with other immune modulators | Alison Louise Tutt, Aymen Al-Shamkhani | 2013-07-09 |
| 7850962 | Human monoclonal antibodies against CD20 | Jessica Teeling, Paul Parren, Arnout Gerritsen, Sigrid Ruuls, Yvo Graus +1 more | 2010-12-14 |